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The protein alpha-synuclein (αS) self-assembles into small oligo-
meric species and subsequently into amyloid fibrils that accumu-
late and proliferate during the development of Parkinson’s disease.
However, the quantitative characterization of the aggregation and
spreading of αS remains challenging to achieve. Previously, we iden-
tified a conformational conversion step leading from the initially
formed oligomers to more compact oligomers preceding fibril forma-
tion. Here, by a combination of single-molecule fluorescencemeasure-
ments and kinetic analysis, we find that the reaction in solution
involves two unimolecular structural conversion steps, from the dis-
ordered to more compact oligomers and then to fibrils, which can
elongate by further monomer addition. We have obtained individual
rate constants for these key microscopic steps by applying a global
kinetic analysis to both the decrease in the concentration of mono-
meric protein molecules and the increase in oligomer concentrations
over a 0.5–140-μM range of αS. The resulting explicit kinetic model of
αS aggregation has been used to quantitatively explore seeding the
reaction by either the compact oligomers or fibrils. Our predictions
reveal that, although fibrils are more effective at seeding than oligo-
mers, very high numbers of seeds of either type, of the order of 104,
are required to achieve efficient seeding and bypass the slow gener-
ation of aggregates through primary nucleation. Complementary cel-
lular experiments demonstrated that two orders of magnitude lower
numbers of oligomers were sufficient to generate high levels of re-
active oxygen species, suggesting that effective templated seeding is
likely to require both the presence of template aggregates and con-
ditions of cellular stress.
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Neurodegenerative disorders such as Parkinson’s disease (PD)and Alzheimer’s disease are becoming increasingly com-
mon as a result of increasing longevity in the population of the
modern world, and there are no effective disease-modifying
therapies to date (1, 2). The main characteristics of these dis-
orders are the deposition and spreading of aggregated proteins
causing neuronal loss that is accompanied with motor and cog-
nitive deficits (3–5).
Alpha-synuclein (αS) is a small (14.5 kDa) intrinsically disor-
dered protein expressed in neurons and presynaptic nerve terminals
(6). It is abundant in the neuronal cytosol of a healthy brain, and its
function is thought to be associated with axonal transport (7, 8). The
assembly of monomeric αS into amyloid fibrils that form Lewy bodies
(LBs) and Lewy neurites is a hallmark of PD (9).
The deposition of αS inclusions in PD follows a common
pattern that correlates with clinical symptoms (10). Furthermore,
transplanted embryonic neurons in patients with PD developed LB
deposits, suggesting that these aggregates can spread (11). Exper-
iments in wild-type and transgenic mice showed that injection of
fibrils of recombinant αS could lead to the aggregation of the en-
dogenous protein, supporting this concept (12–14), and the selec-
tive fate of the aggregate-containing neurons was demonstrated
(15). Although the pathological spreading of αS has now been
reproduced in many laboratories, the molecular mechanism of the
observed phenomenon is not fully understood and this is impor-
tant for rational development of therapies. One emerging expla-
nation is that it occurs by prion-like propagation of αS aggregates
(16, 17). However, the prion-like role of αS in the process of its
pathological spreading is still under debate (18), and alternative
hypotheses exist to explain the observations (16). At the molecular
level, prion-like propagation is linked to the process of templated
seeding, in which the aggregates of αS enter a cell and act as
templates to promote the misfolding and aggregation of cellular
proteins, resulting in an increased number of aggregates that can
then spread to neighboring cells (19). To date, there is a lack of
quantitative investigations of how many aggregates, either oligo-
mers or fibrils, are needed to promote efficiently the aggregation
of soluble αS, to determine and evaluate the conditions when the
templated seeding of αS might be favorable.
To access the quantitative information on the templated seeding
requirements for αS, it is important to achieve a comprehensive un-
derstanding of its aggregation pathway. A concentration-dependence
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study can reveal reaction orders of the key steps in a detailed
molecular-level mechanism of αS aggregation that can be ultimately
used to make predictions of αS seeding behavior. To date, evidence
has been obtained about the mechanism of αS aggregation in so-
lution (20–22) and in the presence of lipid membranes that are
thought to play an important role in vivo (23–25). Single-molecule
studies combined with detailed kinetic analysis have provided us
with an opportunity to define the sequence of events during the
aggregation process in great detail (26–28). Our related studies
using single-molecule fluorescence techniques to follow the aggre-
gation of αS identified a slow conversion step from the initially
formed, proteinase (endopeptidase) K-sensitive oligomers to more
compact, proteinase K-resistant oligomers. We determined the
apparent rates for this process and showed that the converted
oligomers caused the highest damage to neuronal cells (27) and
were stable with respect to the changes in buffer conditions (28).
In the present study, we have extended this approach to analyze
the kinetics of aggregation over a 280-fold range of αS concen-
trations, from 0.5 μM to 140 μM, and used these data to develop an
expanded kinetic model for the aggregation of αS and to determine
the rate constants for the individual steps of the reaction. The
availability of this model, as well as of data acquired over a wide
concentration range, allows us to make quantitative predictions of
the aggregation behavior under a variety of predefined conditions
and calculate the numbers of oligomers and fibrils required for the
templated seeding of αS. This in vitro analysis allows us to assess
specifically the propensity of αS protein to undergo a templated
seeding process and reveals that this process will bypass the slow
nucleation step only under conditions where a high number of
aggregates are present within volumes of the order of the size of a
living cell. Additional quantitative cellular assays reveal that cyto-
toxicity occurs at lower concentrations than those required for
seeding, suggesting that the spreading of αS under more complex
in vivo conditions is likely to involve templated seeding in combi-
nation with complementary cell-mediated processes.
Results
Single-Molecule Förster Resonance Energy Transfer Measurements Show
That αS Oligomers Are Formed at 0.5- to 140-μM Concentrations Within
Several Hours. All of the single-molecule experiments were per-
formed with full-length (140 residues) αS with an alanine to cys-
teine mutation at residue 90 for fluorophore incorporation (A90C).
The attachment of Alexa Fluor dyes to cysteine 90 was demon-
strated to have no significant effect on the kinetics of fibril for-
mation in our previous studies (27, 28), a result attributable to the
fact that this residue is at the periphery of the nonamyloid com-
ponent (NAC) region, which is a key constituent of the αS β-sheet
fibril core. In addition, attachment at this position results in the
fluorophores becoming in close proximity on the formation of
β-sheet structure during aggregation, enabling the conversion
process to be followed by intermolecular Förster resonance energy
transfer (FRET) between dyes located on different monomers.
Therefore, as has been shown in our previous work (27, 28), lower
FRET efficiencies are observed for initially formed oligomers
lacking significant persistent structure, whereas higher FRET ef-
ficiencies are identified for more compact β-sheet-rich oligomers.
We measured αS oligomer formation in solution at physio-
logically related pH at 37 °C, with initial monomer concentra-
tions of 0.5 μM, 5 μM, 10 μM, 35 μM, 70 μM, and 140 μM, using
the single-molecule FRET (sm-FRET) technique to follow the
changes in the numbers of oligomers in the samples within the
first 54 h (see Fig. 2). In these experiments, using αS labeled with
Alexa Fluor 488 (αS-AF488) and Alexa Fluor 594 (αS-AF594),
equimolar quantities of αS-AF488 and αS-AF594 were mixed to
give the chosen starting concentration and allowed to aggregate
(Fig. 1A), and aliquots were withdrawn for the measurements at
the times indicated. Upon withdrawal, the solutions were im-
mediately diluted for single-molecule analysis and continuously
passed through a microfluidic channel to reduce the sampling
time (28, 29) (Fig. 1B). A 488-nm (blue) laser beam was focused
in the center of the channel, to excite the AF488 dye directly, and
the resulting fluorescence was simultaneously collected in both
AF488 (donor) and AF594 (acceptor) channels. AF594-labeled
monomers passing through the confocal volume are undetectable,
whereas AF488-labeled monomers give rise to single bursts in the
donor channel, enabling the level of monomeric αS to be mon-
itored during the aggregation reaction. As oligomers typically
contain both types of label, they are detected as simultaneous
intense bursts in the donor and the acceptor channels, due to the
emission from both the directly excited AF488 and the non-
radiatively excited AF594 via FRET. In this manner, oligomers
can be distinguished from monomers despite the fact that the
latter are found at much higher concentrations; and the oligomer
number and fraction in the solution can be quantified as a function
of the reaction time to give kinetic profiles of oligomer formation.
The analyses of the experimental data are detailed inMethods and
the results are shown in Fig. 2. In addition, the intensities recorded
in both donor and acceptor channels for each oligomer were used
to determine its FRET efficiency value (Eq. 1 inMethods), and the
FRET efficiency values of all oligomers detected in each sample
are shown as a FRET efficiency histogram (Fig. 2B), which con-
tains information on both the number of oligomers in the sample
and their structural characteristics.
Variations in the Number of Oligomers and Their FRET Histograms as a
Function of the Starting Protein Concentration. Within 54 h of the
initiation of the aggregation reaction, oligomer formation was
observed for all concentrations of αS, and the highest concentra-
tions of oligomers were formed in the samples with the highest
initial protein concentrations and varied as a function of the initial
monomer concentration (Fig. 2A). We performed control exper-
iments to verify that we monitor the formation of oligomeric ag-
gregates of αS, using TEM imaging and sm-FRET measurements
with removal of fibrils at late incubation times, as detailed in SI
Appendix, Figs. S1–S3. The FRET efficiency histograms of the
oligomers probed at various time points (Fig. 2B) indicated the
existence of two distinct populations, the initially formed, disor-
dered “low-FRET” and the more compact, “high-FRET” oligo-
mers, in agreement with our previous studies that were carried
out at the 70-μM concentration of αS (27, 28). In these studies,
Fig. 1. Schematic representation of sm-FRET experiment to probe the ag-
gregation of alpha-synuclein (αS). (A) A 1:1 stoichiometric ratio of αS
monomer labeled with Alexa Fluor 488 and Alexa Fluor 594, shown as blue
and orange spheres, was combined at a given initial concentration and
allowed to aggregate. During the process, the monomeric protein as-
sembles into oligomers, the main focus of the present experiments, and then
amyloid fibrils. Aliquots were withdrawn, diluted, and analyzed using a single-
molecule microscope. (B) Schematic of the setup used for the single-molecule
FRET experiments.
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the high-FRET oligomers were found to be more proteinase
K-resistant, more cytotoxic, and more stable toward the changes in
buffer conditions compared with the low-FRET species, confirm-
ing that the changes in the FRET efficiency represent changes in
αS oligomer structure. The experimental data, as described pre-
viously, were divided into groups with different oligomer apparent
sizes, based on the number of peaks that were resolvable in the
FRET efficiency histograms, as shown in SI Appendix, Fig. S4. The
groups included “small” oligomers containing 2–5 monomer units
(-mers) which showed one peak in the FRET histograms, and
“large” oligomers containing 6–150-mers where two peaks could
be identified in the FRET histograms. Species composed of more
than 150-mers, and species occupying neighboring time bins, typi-
cally observed in the samples past the first day of incubation, were
assumed to arise from fibrils and excluded from the measurements
(SI Appendix, Fig. S3). The apparent size estimation was based on
oligomer brightness, as discussed in detail in SI Appendix, and the
overall distributions are shown in SI Appendix, Fig. S8. This
shows that the majority of the species detected at all times in the
aggregation reaction were smaller than 10-mers. We also per-
formed additional total internal reflection fluorescence micros-
copy (TIRFM) measurements to confirm these results, as detailed
in SI Appendix, Fig. S9. In the case of the measurements made on
samples with the initial concentrations of 35–140 μM, one FRET
peak was observed in the histograms of the small oligomers at
all aggregation times, which could be fitted to a single Gaussian
distribution (SI Appendix, Eq. S1) centered at a FRET efficiency
value (E) of 0.5 (SI Appendix, section 1.1). For large oligomers,
two populations could be distinguished, particularly at late ag-
gregation times, and the histograms were globally fitted to double
Gaussian functions (SI Appendix, Eq. S1), with E values of 0.4 and
0.6 (Fig. 2B and SI Appendix, section 1.1). These two populations
were assessed to have distinctly different kinetic profiles, with the
low-FRET population appearing and increasing within the first
Fig. 2. Results of the sm-FRET experiment. (A) Kinetic profiles of oligomer formation and monomer depletion, plotted against the incubation time (SEM, N = 6,N
is a separate sample). Of note, the increase in the oligomer concentrations for 0.5-μM solutions is present and the resulting species are in the low-nanomolar
range, which is not readily visible on the scale in A. Magnification is shown in SI Appendix, Fig. S7A. (B) Representative FRET efficiency histograms, resulting from
sm-FRET aggregation experiments with initial protein concentrations of 5 μM, 10 μM, 70 μM, and 140 μM, detected over 400 s. The data were split into two
apparent size groups: small (2–5 monomer units) and large (6–150 monomer units) oligomers. For the large oligomers, illustrative fits to Gaussian functions are
shown in blue (SI Appendix, Eq. S1), and the resulting mean FRET efficiency values, E, were as follows: for 5 μM, 9 h, E = 0.34, and 27 h and 51 h, global E = 0.49; for
10 μM, 9 h, E = 0.33, and 27 h and 51 h, global E = 0.52; for 70 μM, global E(low-FRET) = 0.37 and global E(high-FRET) = 0.71; for 140 μM, global E(low-FRET) = 0.44
and global E(high-FRET) = 0.67. Further details of the fitting functions and the resulting average parameters (N = 6) are given in SI Appendix, section 1.1.
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24 h of the experiment, but the high-FRET population reaching
a maximum value at longer times. They were assigned to the two
types of αS oligomers reported previously (27), the low-FRET
and the high-FRET oligomers, and the time dependence of these
two populations was monitored separately. The kinetic traces for
these low- and high-FRET species separately are shown in
Fig. 3B. Examination of the histograms obtained for the lowest-
concentration samples (0.5 μM) showed that only the low-FRET
population could be observed for the studied aggregation period
(SI Appendix, Fig. S7B). For the 5-μM and 10-μM samples, the
low-FRET distribution was clearly detectable during the first 9 h
of the measurements, whereas at later times the histograms showed
a much broader single distribution, and the overall oligomer con-
centrations were extracted without separation into the low- and
high-FRET subpopulations (Fig. 2B).
Reactive Oxygen Species Measurements. We previously reported
that oligomers can be taken up rapidly by neurons and astrocytes
and that the high-FRET oligomers promote the production of
reactive oxygen species (ROS) when applied to primary neuronal
cultures (27). To check whether the oligomers of αS generated in
these experiments were able to cause cellular damage, we per-
formed ROS assays and found that the oligomers prepared at
either 70 μM or 5 μM initial protein concentration induced the
production of ROS, as detailed in SI Appendix, section 1.8 and Fig.
S15. Subsequently, we performed a series of ROS measurements
to determine the lowest concentration of aggregates needed to be
added to produce detectable ROS (SI Appendix), and this con-
centration was around 50 pM, which corresponds to 30 oligomers
per volume approximately corresponding to a single cell (10 μm)3.
The Critical Aggregation Concentration of αS Is Submicromolar. We
measured the critical aggregation concentration (CαS) of αS under
the conditions used in this study, by estimating the total concen-
tration of both monomers and oligomers that were released from
αS fibrils after prolonged incubation of the fibrils in pure buffer
solution. TEM images of the samples of fibrils after the incubation
in buffer are in SI Appendix, Fig. S10, and confirm oligomer release
from the fibrils, in agreement with the observations in our previous
work (27). The CαS value corresponds to the total concentration of
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Fig. 3. Modeling the kinetics of αS aggregation. (A) The model considers a coarse-grained conversion reaction between oligomeric populations as a whole,
with no size dependence, and allows fibrils to grow once formed. Here, unimolecular conversions with no monomer dependence are assumed between
populations (an alternative model with bimolecular conversions is presented in SI Appendix, Fig. S12A). (B) The resulting nucleation–conversion–polymeri-
zation model is used to describe the observed populations, whereby monomer units form low-FRET efficiency oligomers with rate constant kn and an average
reaction order of n. These oligomers can then convert to ordered high-FRET efficiency oligomers via a first-order reaction with rate constant k1
c, with a
subsequent final first-order conversion to fibrils with rate constant k2
c. Fibrils can then recruit single-monomer units to grow in a succession of elongation
steps, with a length-independent rate constant k+. At early reaction times, reverse reactions can be neglected, and conversion constants were fixed as equal
such that k1
c = k2
c ≡ kc .The resulting simplified model, with four free parameters, was fitted globally to early-time (up to 33 h) kinetic data showing changes
with time in monomeric and oligomeric populations for a range of initial monomer concentrations. The resulting nucleation reaction order was found to be
n = 0.90 ± 0.1 with rate constants kn = (4.0 ± 2.0) × 10
−4 μM1−n h−1, kc = (9.5 ± 5.0) × 10−2 h−1, and k+ = (9.0 ± 7.0) × 10−2 μM−1 h−1.
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monomer present in equilibrium with fibrillar aggregates and was
measured in supernatants after removal of fibrillar pellets by ul-
tracentrifugation. This approach yielded a value of 0.7 ± 0.2 μM.
The method used for the CαS measurement is fully described in SI
Appendix, section 1.7. This CαS value is lower than the result in an
earlier report, 28 μM, which was measured using quantitative
amino acid analysis (20). It is closer to a more recently reported
value of ca. 2.7 μM, which was obtained from absorption mea-
surements of denatured supernatants and subsequent extrapola-
tion to the situation exploring the absence of denaturant (30).
Kinetic Analysis.
Two simple models are consistent with the kinetic data. In our previous
study of the aggregation of αS (27), we identified a conversion
from relatively disordered low-FRET oligomers to more com-
pact high-FRET oligomers and were able to perform the kinetic
analysis of these data to provide the rate of this conversion. In
light of the previously unidentified experimental information on
the different protein species formed during the aggregation of
the protein at different concentrations, we have been able to
expand the model obtained in the previous study. This yielded an
explicit and, importantly, predictive aggregation model. Similar
to the earlier analysis, we replace the simplified nucleated poly-
merization models (31–33), in which monomeric units are in direct
equilibrium with fibrillar structures, by nucleation–conversion–
polymerization models (34), which introduce a series of confor-
mational conversion steps before fibril formation. Such a class of
models can be solved analytically for early reaction times, allowing
a global fit to both monomeric and oligomeric data. The simplest
such model considers a general mechanism whereby low-FRET
oligomers are formed from monomeric units in solution. These
low-FRET oligomers then convert to high-FRET oligomers,
which in turn convert into fibrils (Fig. 3A). Fibrils then grow by
monomer addition as has been inferred from the observation that
the elongation of the fibrils is initially linear in monomer con-
centration (22). The assumption of the on-pathway nature of the
oligomers is supported by multiple observations. The presence of
the lag phase in the formation of high-FRET oligomers relative to
that of the low-FRET oligomers suggests that these species orig-
inate from the rearrangement of their preceding low-FRET spe-
cies, as an off-pathway relationship cannot generate such an effect.
This is further confirmed by the oligomer release upon fibril dis-
aggregation (SI Appendix, Fig. S10), which was previously dem-
onstrated to occur with the high-FRET oligomers being released
at early times, followed by the low-FRET species upon longer
incubations (27). By the principle of microscopic reversibility this
shows that both high- and low-FRET species are on the pathway
to form fibrils. In addition, we have recently demonstrated a
correlation between the rates of the oligomer and fibril formation
for αS and its pathological mutants, particularly the inhibition of
both of these processes for the A30P variant, further supporting
the oligomer on-pathway nature (35). Additionally, from the
TEM imaging experiments of aggregation and disaggregation
(SI Appendix, Figs. S2 and S10), the diameters of oligomers and
fibrils generated in these experiments appear comparable. Finally,
we can directly observe that oligomers can elongate in the pres-
ence of freshly added αS monomer, using TIRFM imaging (SI
Appendix, Fig. S11). Because sm-FRET data suggest that oligo-
mers account for a very small percentage of total system mass
throughout the aggregation reaction, this allowed a coarse-grained
treatment of each oligomer population (described in Methods).
The dependence of these conversion processes on oligomer size
has only a very minor effect on the overall conversion kinetics and
thus does not enter the analysis and we consider only an average
overall flux between populations. These considerations do not,
however, discriminate between different possible reaction orders
of the conversion reactions, and so both a monomer-independent
unimolecular conversion model (Fig. 3A) and a monomer-
dependent bimolecular conversion model (SI Appendix, Fig. S12A)
were considered. Finally, both models were simplified by setting
the conversion rate constant for the low-FRET to high-FRET
oligomer conversion step equal to that for the high-FRET olig-
omer to fibril conversion, because allowing these rate constants
to differ introduces an extra free parameter to the fitting pro-
cedure in each case, yet makes no significant difference to the
quality of the fits. The kinetic equations and method used are
discussed in further detail in Methods.
We were thus able to use both the unimolecular and the bi-
molecular conversion models to fit the kinetic data over the
entire concentration range, particularly the oligomer concentra-
tions (Fig. 3B and SI Appendix, Fig. S12B), to extract rate con-
stants and a nucleation reaction order. A summary of the results
is given in Fig. 3, and the obtained values are in agreement with
our earlier studies (27, 28). In both cases we obtain a nucleation
reaction order n close to one, suggesting that the initial nucle-
ation step governed by kn is a nonelementary step, for example a
change in conformation, that can be resolved in principle into a
series of steps by more detailed modeling.
A unimolecular conversion model explains the observed intermediate-FRET
histograms at low concentrations.To distinguish between a unimolecular
conversion mechanism and a bimolecular conversion mechanism,
both models were used with their fitted rate constants to predict the
numbers of low-FRET and high-FRET oligomers with reaction time
at concentrations below 10 μM, and these predictions are shown in
Fig. 4. A unimolecular conversion model predicts similar and stable
relative abundance of low-FRET and high-FRET oligomers up to
54 h during aggregation reactions under these conditions, whereas a
bimolecular model predicts much larger variations with time be-
tween and within each population. The former finding is consistent
with the observation of blurred single-FRET peaks at these con-
centrations, shown in Fig. 2B; the observed FRET behavior is
intermediate between the low-FRET and high-FRET extremes,
whereas a bimolecular model would predict significant dominance
of the low-FRET population’s contribution to the overall FRET
behavior. A unimolecular conversion model is thus preferred and
retained for further study below. The unimolecular conversion
model gives a rate constant for each conversion step of 9.5 × 10−2 h−1,
giving a half-life of each of the conversion steps of the aggregation
reaction, outlined in Fig. 3A, of about 7 h. The overall charac-
teristic reaction time, measured by an inflection in the production
of fibril mass with time, is given by this model as 34 h for 140 μM
and 183 h for 0.5 μM. The value of k+ obtained here, 25 M−1 s−1,
for the addition of monomer to a short fibril is slower than that
obtained for the addition of monomer to large fibrils under similar
but not identical conditions (22). This suggests that the short fibrils
formed early in the aggregation process still differ in structure
from mature fibrils.
Seeding predictions from the unimolecular conversion model. In templated
seeding, the addition of preformed aggregates to the protein so-
lution causes the acceleration of the aggregation reaction (36).
Seeding by αS fibrils has been efficient in vitro (22, 37). However,
determining whether oligomers of αS can also take part in the
process of seeding has been difficult experimentally, because they
are present in low concentrations during the aggregation process,
their different types are hard to isolate and stabilize, and the pre-
cise quantification of these seeds before their addition remains
challenging. Experimental evidence exists for both the promotion
(38) and the inhibition (39) of aggregation reaction induced by
various αS oligomers.
Having established the extended kinetic model that is consis-
tent with all of the experimental data, we used this model to
explore the impact of seeding with either high-FRET oligomers
or small fibrils. Low-FRET oligomers were not considered in this
analysis owing to their demonstrated lower stability (27, 28). We
determined the concentrations of either high-FRET oligomers or
small fibrils that are required to double the initial aggregation rate
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of αS over a 1010-fold range of the different initial concentrations
of αS (SI Appendix, Fig. S13). According to the predictions, lower
concentrations of fibrils than of oligomers are required to double
the aggregation rate of αS, meaning that fibrils will be more prone
to seed this reaction if present at equal concentrations. In addi-
tion, we assessed how sensitive the system is to seeding over the
explored αS monomer concentration range, by looking at the ratio
of the monomer concentration to seed concentration, termed
“effectiveness” (SI Appendix, Fig. S13). The results reveal that the
impact of seeding will vary, depending not only on the nature of
the seeds, but also on the initial αS monomer concentration (34);
below 10 nM of monomeric αS seeding by either type of aggre-
gates will be relatively ineffective, whereas it will become effective
between 10 nM and 1 μM and particularly prominent at the con-
centrations above 1 μM.
To assess the role of seeds in αS aggregation at more physi-
ologically related conditions, we estimated the numbers of olig-
omers or fibrils that would need to be introduced to a volume
approximately corresponding to a single cell (10 μm)3 to double
the aggregation rate in the presence of a set of chosen initial
concentrations of αS, which include the range of reported in vivo
concentrations of αS (40, 41). According to the kinetic model,
above the CαS the seeding will result in the formation of fibrils,
whereas below the CαS it will lead to faster production of oligo-
mers. Table 1 summarizes these predictions, and the first column
lists the initial concentrations of αS, followed by columns con-
taining the numbers of either high-FRET oligomers or fibrils that
are required to be added to these initial concentrations to double
the aggregation rate. In addition, Table 1 includes the concen-
trations of αS monomer that would be needed to prepare the
required oligomer seed numbers during the aggregation process.
Following these predictions, if the monomer concentration is
2 μM, 10,000 fibrils are needed, or 16,000 high-FRET oligomers,
and an approximately five times higher (9.4 μM) concentration of
αS monomer would be required for the production of this number
of oligomers. We investigated how the resulting seed numbers vary
upon either lowering or increasing the initial concentration of αS,
as illustrated in Table 1, and the required seed numbers remained
in the order of thousands of species. For example, at 2 nM con-
centration, which is the lowest αS concentration considered in this
analysis, 2,700 high-FRET oligomers or 2,400 fibrils are needed
to double the aggregation rate. The seed numbers at 3 μM and
4 μM of initial αS, mimicking the conditions of the protein over-
production (42, 43), are also included (Table 1).
To investigate the effects of the elevated concentration of the
initial monomeric αS on the aggregate production, we used the ki-
netic model to estimate the number of oligomers that would be
formed in a 48-h period at the initial αS monomer concentration of
2 μM in the (10 μm)3 volume and determined how this number
changes if the concentration is 3 μM instead (SI Appendix, Fig. S14).
This analysis shows that the simulated cell-like volume would contain
about 104 oligomers in a period of 48 h, if there was no inhibition
of the aggregation reaction. This number is again large, of the same
order of magnitude as the numbers of species required for seeding,
although, for example, the number of proteasomes available for the
degradation in a biological cell was estimated to be about 1 million
(44). However, if the oligomers were degraded significantly slower
than monomers, then oligomer formation could reduce the overall
rate of proteasomal degradation in a cell. Interestingly, the conse-
quence of the increased initial monomer concentration of αS from
2 μM to 3 μM in this simulation is that higher concentrations of both
oligomers and fibrils are produced at all times up to 48 h (SI Ap-
pendix, Fig. S14). Considering the ability of oligomers to cause cel-
lular damage, demonstrated in this and other studies (45), this
observation is consistent with the established correlation between an
increase in the concentration of αS and pathology.
Discussion
Here, we have exploited single-molecule FRET microscopy to
study the initial steps of αS aggregation and explored systematically
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Fig. 4. Predictions of αS aggregation kinetics at low concentrations by nucleation–conversion–polmerization models. After fitting to the available kinetic
data, both unimolecular (Fig. 3) and bimolecular (SI Appendix, Fig. S12) conversion models were used to predict how the concentrations of low-FRET efficiency
oligomers and high-FRET efficiency oligomers vary over time at low initial monomer concentrations; the fitting was carried out by considering only the total
concentration of oligomers at these low monomer concentrations. As the fitting was carried out over a reaction time of 33 h and overlaid over 54 h, a similar
time range was used for the predictions. From the first two columns, it is clear that a unimolecular conversion model alone predicts similar concentrations of
both types of oligomers and furthermore predicts a ratio of concentrations that is very stable with changing initial monomer concentration. These predictions
are consistent with the single-peak FRET histograms at low concentrations shown in Fig. 2B.
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the formation of oligomers over a range of the starting protein
concentrations from 0.5 μM to 140 μM. We then developed an
extended kinetic model to analyze the experimental data over the
full range of the examined αS concentrations, which allowed an
estimation to be made of the rate constants of the main micro-
scopic steps of the reaction shown in Fig. 3A, and making pre-
dictions of the number of αS seeds required to increase the
aggregation rate, providing an insight into the conditions when the
process of templated seeding might be favorable.
Following our predictions, templated seeding by fibrils will en-
able the aggregation reaction to proceed to growth of more fibrils
by monomer addition, without the steps dependent on the
formation and conversion of oligomers. Seeding is expected to
be particularly effective at minimum concentrations of αS above
1 μM (SI Appendix, Fig. S13), supporting the importance of αS
concentration elevation in the disease. To quantify the number of
seeds required to affect the aggregation rate of αS in a volume
approximately corresponding to a single cell (10 μm)3, we esti-
mated how many oligomers or fibrils would need to be introduced
to this volume to double the aggregation rate of αS (Table 1).
Clearly, these calculations do not aim to address various complex
factors of the cellular environment, among which are, for example,
the presence of cellular organelles and lipid surfaces, or altered
salt content and pH that could increase the number of aggregates
(22, 25), or molecular chaperones (46) and protein degradation
systems (47), which prevent aggregate formation and remove ag-
gregates once formed. Nevertheless, the predicted seed numbers
based on our analysis provide a quantitative insight into the re-
quirements to observe effective templated seeding of αS in vitro,
which is significant because quantification of this process is cur-
rently lacking due to experimental difficulties in its elucidation.
The predicted numbers of aggregates are large, in the order of 104
species per cell-like volume, values that correspond to micromolar
concentrations of the aggregates, requiring multiple species to
enter this volume at the same time. These requirements for the
templated seeding of αS are relatively high in comparison with, for
example, recently reported results for tau K18 using a similar
approach (26). It is interesting to note that our kinetic analysis can
be used to predict some of the conditions when a small number of
oligomers or fibrils may be effective at seeding the aggregation
reaction, and hence templated seeding might readily occur. Two
factors appear to be important for this process to be favorable.
The first determining factor is the nucleation rate, and if the nu-
cleation rate is slow then a small number of oligomers or fibrils are
most effective. For example, if the nucleation rate of αS is reduced
in our model by a factor of 103, which is close to the published
nucleation rate for the tetrapeptide repeat of tau (26), but all of
the other rates remain the same, then the number of high-FRET
oligomers required to double the initial aggregation rate at 2 μM
in the (10 μm)3 volume would be reduced ∼39-fold, from 16,000 to
410. For a single high-FRET oligomer to be required for tem-
plated seeding, the nucleation rate constant of αS must be reduced
by a markedly larger factor of 108. The other determining factor is
the initial protein concentration and whether it is above or below
the critical aggregation concentration, which at our conditions was
found to be 0.7 μM for αS. At 2 μM, above the critical aggregation
concentration, 16,000 oligomers are needed whereas below it, at
0.2 μM, only 5,900 oligomers will be sufficient. These oligomers, if
added to a hypothetical cell, will lead to the faster formation of
more oligomers, but not fibrils. Therefore, templated seeding will
be more effective at low concentrations of free monomer.
It is interesting to discuss our seeding predictions in the context
of prion-like propagation of αS, because the processes of tem-
plated seeding and prion-like spreading have been frequently
linked in the literature (16). However, despite occurring at the
same time, the processes can be distinguished at the molecular
level, as is schematically illustrated in Fig. 5, and the templated
seeding mechanism constitutes only a part of the spreading pro-
cess. Templated seeding results in an accelerated production of
protein aggregates. In isolation, this would lead to the formation
of aggregates and be followed by their passive diffusion (Fig. 5B).
To achieve sustainable aggregate-driven spreading and prevent
dilution of aggregates as they propagate from cell to cell, a process
of aggregate amplification is essential in addition to templated
seeding (Fig. 5C). In combination, these two processes would create
a positive feedback loop, involving aggregate production and mul-
tiplication, resulting in the aggregate-driven (prion-like) spreading of
αS, schematically shown in Fig. 6A. Therefore, effective prion-like
spreading of αS in vivo requires a combination of conditions favoring
both the templated seeding and the aggregate amplification pro-
cesses. However, although αS aggregate amplification was demon-
strated in vitro at low pH (22), we detected no amplification at
neutral pH in these experiments and thus additional cellular-based
processes are needed, not included in the kinetic model, to achieve
the aggregate amplification required for sustained spreading.
We have found that the oligomers of αS produced during the
aggregation process are neurotoxic, which is consistent with our
previous work (27). Using ROS measurements, we estimated that
the numbers of oligomers required to promote the production of
ROS in neuronal cells under our experimental conditions are in the
order of tens of oligomers, which is similar to earlier results
reported for amyloid-beta peptide, where cellular damage was
found to occur when a single oligomer entered a recipient cell
(48). The numbers of aggregates required for ROS production are
therefore two orders of magnitude lower than what is required for
the templated seeding, and this difference suggests that the tem-
plated seeding by the oligomers occurs less readily than the cel-
lular damage caused by the aggregates themselves. This idea is
Table 1. Summary of predicted seed concentrations and numbers required to double the initial aggregation rate
Total
concentration/μM
High-FRET oligomer
seeding required
to double initial
rate/μM
No. of high-FRET
oligomers implied
in a (10 μm)3
cell-like volume
Initial monomer
concentration required to
produce this concentration
of high-FRET oligomers
during the aggregation
reaction/μM
Fibril seeding
required to double
initial rate/μM
No. of fibrils
implied in a
(10 μm)3 cell-like
volume
2 0.0271 16,000 9.4 0.0174 10,000
0.2 0.0098 5,900 2.9 0.0079 4,700
0.02 0.0048 2,900 1.3 0.0042 2,500
0.002 0.0045 2,700 1.2 0.0039 2,400
3 0.0326 20,000 11.8 0.0199 12,000
0.003 0.0044 2,600 1.1 0.0038 2,300
4 0.0373 22,000 13.8 0.0218 13,000
0.004 0.0043 2,600 1.1 0.0038 2,300
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consistent with the long-established link between oxidative stress
and neurodegeneration (49) and the fact that the oxidative reac-
tions can promote the aggregation of αS (50), and it is corroborated
by experimentally observed correlation between αS seeding and cel-
lular toxicity (15). Based on our findings, we hypothesize that for
small aggregates in vivo, if templated seeding occurs, it is under
conditions of raised levels of ROS, which in turn may promote αS
aggregation, resulting in the aggregate spreading in a cell-driven
way that does not strongly depend on the seeding effectiveness,
as illustrated in Fig. 6B. Because our results suggest that cellular
stress is required for sustained spreading, and larger αS fibrils were
previously found less effective at exerting it (27), this implies that
a larger number of fibrils than of oligomers will be required for
the spreading to occur. Taken together, our quantitative analysis
suggests that the mechanism of templated seeding by oligomers or
fibrils is unlikely to solely drive the spreading of αS aggregates in
PD, because this will always occur under conditions of cellular
stress. Ultimately, this suggests that reducing cellular stress may be
a possible therapeutic strategy to prevent the spread of disease
through the brain.
Summary
We have characterized the early stages of αS aggregation, using
in vitro single-molecule experiments and kinetic analysis. Our pro-
posed model treats the initially formed low-FRET oligomers, the
more compact high-FRET oligomers, and the fibrils of αS as distinct
species, requiring successive conversion steps. The combination
of single-molecule measurements and kinetic analysis used in
this study has provided a quantification of αS aggregates in
seeding the aggregation process, which is important in the context
of PD, and the approach is applicable to other peptides and pro-
teins that are likely to be involved in neurodegenerative diseases.
Methods
αS Sample Preparation for sm-FRET. Monomeric full-length A90C and wild-
type αS were expressed and purified according to a previously described
protocol (51). A90C was labeled with maleimide-linked Alexa Fluor 488
(AF488) or Alexa Fluor 594 (AF594) (Life Technologies) and separated from
the free dyes according to the previously reported protocol (27, 28, 52).
Aliquots were flash-frozen, stored at –80 °C, and thawed once before use.
For sm-FRET aggregation experiments, a 1:1 molar ratio of AF488- and
AF594-labeled monomeric αS was combined in Tris buffer (25 mM Tris, 0.1 M
NaCl, pH 7.4) with 0.01% NaN3, up to a starting protein concentration of
0.5 μM, 5 μM, 10 μM, 35 μM, 70 μM, or 140 μM and a sample volume of 300 μL.
It is established that αS aggregation in vitro can be promoted by constant
agitation (53); therefore the solutions were incubated in the dark at 37 °C with
constant agitation at 200 rpm (New Brunswick Scientific Innova 43), and
aliquots were withdrawn at regular intervals for sm-FRET experiments. The
purity of the starting material was confirmed by sm-FRET measurements of
the samples before the incubation.
sm-FRET Data Acquisition. Aliquots from the dual-labeled aggregating sam-
ples were diluted by a serial dilution of 103- to 105-fold in Tris buffer at room
temperature immediately before the measurement, a concentration suitable
for single-molecule analysis, keeping the multiple-occupancy events negli-
gible. The analyzed solution was introduced into an inlet of a straight-
channeled microfluidic device (PDMS; 25 μm height, 100 μm length) via a gel-
loading tip and passed through the channel at a constant rate of 2 cm/s by a
syringe pump (PHD2000; Harvard Apparatus), according to the previously
reported method (29).
The setup used for single-molecule measurements (Fig. 1B) is analogous to
one previously described (54). For the FRETmeasurement, a collimated 488-nm
laser beam (Spectra Physics NewPort Cyan) was directed through a back port
of an inverted microscope (Nikon Eclipse Ti-U) at 2 mW power (measured at
the back port of the microscope), where it was reflected by a dichroic mirror
(Semrock DiO1 R405/488/594) and sent through an oil immersion objective
(Plan Apo VC 60 x, NA 1.40; Nikon) to be focused 10 μm into the center of the
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Fig. 5. Schematic representation of the processes required for αS spreading.
(A) Seeding results in the formation of aggregates from monomeric protein,
and amplification involves the multiplication of existing aggregates. (B) The
seeding process alone would not lead to efficient spreading due to the pos-
sibility that the formed aggregates would be diluted out. (C) The combination
of seeding and amplification can lead to continuous aggregate spreading.
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Fig. 6. Schematic outline of two simplified models of αS aggregate spreading
in a cellular environment. (A) Aggregate-driven, or prion-like, propagation of
aggregated species. The primary role of the aggregate upon entering a cell is
to induce the aggregation of monomeric protein by the mechanism of tem-
plated seeding. (B) Cell-driven model. The initial role of the aggregate is to
induce cellular stress, which disrupts the homeostasis and creates conditions
where protein aggregation becomes favorable.
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microfluidic channel. Fluorescence signal was collected by the same objective,
imaged onto a 100-μm pinhole (Thorlabs), and separated into two channels by
a dichroic mirror (Horiba 585DRLP). Donor fluorescence was filtered by a long-
pass (Edge Basic 514) and a band-pass filter (535AF45; Omega Filters) before
being focused onto an avalanche photodiode (APD) (Perkin-Elmer). Acceptor
fluorescence was directed through a long-pass filter (610ALP; Horiba) and a
band-pass filter (BrightLine 629/53) before being focused onto a second APD.
Synchronous output from the APDs was collected by a custom-implemented
field-programmable gate array (FPGA) (Celoxica RC10). Data were acquired for
400 s (80 frames, 100,000 bins per frame, 50 μs bin width) per aliquot and
consisted of time-binned photon bursts in the donor and the acceptor channel
(SI Appendix, Fig. S5). It was verified that the chosen experimental conditions
and the detection time led to the stable rate of coincident events (SI Ap-
pendix, Fig. S6), suggesting the absence of oligomer dissociation during
the measurements.
sm-FRET Data Analysis. Data were analyzed using custom-written Igor Pro
(Wavemetrics) code, according to a previously reportedmethod (28). Time bins
with intensities greater than 15 photons per bin in the donor (emission from
AF488) and the acceptor (AF594) channel simultaneously (the AND criterion)
(55) were assigned to be due to oligomeric events and selected for the
analysis. The donor counts that did not fit the criterion but were above the
applied threshold were saved separately and assigned as monomeric αS
bursts. The threshold of 15 photons per bin for both channels was de-
termined using the previously established optimized threshold selection
method (56). The values of the photon bursts were corrected for the crosstalk
and the autofluorescence from the donor to acceptor channels according to
ID   =   ðD  −   ADÞ, where ID is the modified intensity in the donor channel, D is
the original intensity in the donor channel, AD is the autofluorescence in the
donor channel (1.6 photons per bin, the average signal from buffer only), and
IA = ðA−AA −C ×DÞ, where IA is the modified intensity in the acceptor
channel, A is the original intensity in the acceptor channel, AA is the auto-
fluorescence in the acceptor channel (1.3 photons per bin), and C is the
crosstalk from donor to acceptor channel (13%). The crosstalk was negligible
from the acceptor to donor channel.
For every simultaneous oligomeric burst, the FRET efficiency was cal-
culated as
E=
IA
ðIA + γ   IDÞ [1]
where ID is the donor intensity in the presence of an acceptor, IA is the ac-
ceptor intensity, and γ is the gamma factor specific to the instrument (0.99),
which accounts for the relative detection efficiencies of the dyes and their
quantum yield.
The FRET efficiency values were binned into histograms with bin width of
0.05 (Fig. 2).
Subsequently, the data were split into two size groups: small (2–5-mers)
and large (6–150-mers). Large species, either occupying consecutive time
bins or greater than 150-mers, were excluded from the analysis as de-
tailed in Horrocks et al. (29). At small sizes, one peak was observed in the
FRET efficiency histograms in all measured samples (SI Appendix, Fig. S4).
At large sizes, either one (0.5–10 μM) or two (35–140 μM) FRET efficiency
peaks could be distinguished. The two distinguishable peaks were as-
signed to be due to low-FRET oligomers and high-FRET oligomers. The
FRET efficiency histograms were integrated to give oligomer kinetic traces,
as detailed in SI Appendix, section 1.1. For 0.5- to 10-μM samples, the
overall change in oligomer populations was obtained. For 35- to 140-μM
samples, the separate kinetic traces for low-FRET and high-FRET oligomers
were resolved.
Kinetic Analysis. The following kinetic moment equations were used to model
the aggregation of αS, neglecting the relatively slow reverse conversions and
depolymerization reactions.
For the monomer-independent unimolecular conversion model,
_P1ðtÞ=   knmðtÞn −  kc1P1ðtÞ,
_P2ðtÞ=   kc1P1ðtÞ−  kc2P2ðtÞ,
_P3ðtÞ=   kc2P2ðtÞ,
_M1ðtÞ=   nknmðtÞn −  kc1M1ðtÞ+  2k+1mðtÞP1ðtÞ,
_M2ðtÞ=   kc1M1ðtÞ−  kc2M2ðtÞ+ 2k+2mðtÞP2ðtÞ,
_M3ðtÞ=   kc2M2ðtÞ+2k+mðtÞP3ðtÞ,
mðtÞ=   mtot −M1ðtÞ−M2ðtÞ−M3ðtÞ.
[2]
For the monomer-dependent bimolecular conversion model,
_P1ðtÞ= knmðtÞn −mðtÞ  kc1P1ðtÞ,
_P2ðtÞ=mðtÞ  kc1P1ðtÞ−mðtÞ  kc2P2ðtÞ,
_P3ðtÞ=mðtÞ  kc2P2ðtÞ,
_M1ðtÞ=nknmðtÞn −mðtÞ  kc1M1ðtÞ+ 2k+1mðtÞP1ðtÞ,
_M2ðtÞ=mðtÞ  kc1M1ðtÞ−mðtÞ  kc2M2ðtÞ+ 2k+2mðtÞP2ðtÞ,
_M3ðtÞ=mðtÞ  kc2M2ðtÞ+ 2k+mðtÞP3ðtÞ,
mðtÞ=mtot −M1ðtÞ−M2ðtÞ−M3ðtÞ,
where P1 is the number concentration of low-FRET oligomers, P2 is the number
concentration of high-FRET oligomers, P3 is the number concentration of fi-
brils, M1 is the mass concentration of low-FRET oligomers (concentration of
monomer residues involved), M2 is the mass concentration of high-FRET olig-
omers (concentration of monomer residues involved), M3 is the mass concen-
tration of fibrils (concentration of monomer residues involved), m(t) is the
concentration of free monomer units, mtot is the total concentration of mono-
mer in the system, k1
+ is the rate constant governing growth of low-FRET olig-
omers, and k2
+ is the rate constant governing growth of high-FRET oligomers. All
other symbols are defined in Fig. 3 and SI Appendix, Fig. S12.
These moment equations are derived by taking sums of the system’s kinetic
master equations over the length distribution of each species, as previously
described (31–34). Both models are first linearized for early times by taking
mðtÞ =   mtot (discarding the last equation in each case) and then solved ana-
lytically using the Mathematica 10.0 software package, to obtain closed-form
expressions for each population. Initial conditions were chosen according to the
seeding scenario explored (for data fitting, unseeded conditions are represented
by P1ð0Þ=   P2ð0Þ=   P3ð0Þ=   M1ð0Þ=   M2ð0Þ=   M3ð0Þ= 0 and mð0Þ=   mtot. The
resulting expressions were then globally fitted to experimental data up to 33 h
for a range of values for mtot via a weighted least-squares Levenberg–Mar-
quardt algorithm, leaving all rate constants and the nucleation reaction order
free (Fig. 3 and SI Appendix, Fig. S12). The negligible mass of oligomers ob-
served throughout the aggregation reaction suggests that the consumption of
monomer mass by growth of oligomers can be neglected; terms involving k+1
and k+2 were thus neglected in both models, with no adverse effect observed
on the quality of the resulting fits. Furthermore, kc1 and k
c
2 were equated into a
single parameter kc in each model, as described in Kinetic Analysis.
The overall characteristic reaction time ta in the unimolecular model, mea-
sured by the time at which an inflection is observed in the fibril mass concen-
tration M3ðtÞ without linearization of the equations, is given to a good
approximation by ta =   ð2  k+ knmntotÞ−1=2 +   2  k−1c as described previously (34).
For seeding simulations, a doubling in the initial reaction rate was quantified by
considering a halving in the 10th time of the reaction upon seeding, that is, the
time taken for the fibril mass concentration M3ðtÞ to reach mtot=10, which lies
within the range of validity of the linearized early time solution described above.
ACKNOWLEDGMENTS. We thank Nadia Shivji and Beata Blaszczyk for αS pro-
tein expression, Peter Jönsson for help with preliminary total internal reflec-
tion fluorescence microscopy (TIRFM) imaging experiments, Chris Taylor for
help with preliminary autodilution experiments, and Michel Goedert for crit-
ical reading of the manuscript. M.I. is funded by a Tayyeb-Hussain Scholarship.
G.A.G. is funded by the Schiff Foundation. S.G. is funded through a Wellcome
Trust Intermediate Clinical Fellowship. Funding from the Frances and Augustus
Newman Foundation, the European Research Council, and the Biothechnology
and Biophysical Sciences Research Council is gratefully acknowledged.
1. Dorsey ER, et al. (2007) Projected number of people with Parkinson disease in the
most populous nations, 2005 through 2030. Neurology 68(5):384–386.
2. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the
global burden of Alzheimer’s disease. Alzheimers Dement 3(3):186–191.
3. Dobson CM (2003) Protein folding and misfolding. Nature 426(6968):884–890.
4. Prusiner SB (2012) Cell biology. A unifying role for prions in neurodegenerative dis-
eases. Science 336(6088):1511–1513.
5. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease.
Annu Rev Biochem 75:333–366.
6. George JM (2002) The synucleins. Genome Biol 3(1):S3002.
7. Bonini NM, Giasson BI (2005) Snaring the function of alpha-synuclein. Cell 123(3):359–361.
8. Iwai A, et al. (1995) The precursor protein of non-A beta component of Alzheimer’s disease
amyloid is a presynaptic protein of the central nervous system. Neuron 14(2):467–475.
9. Spillantini MG, et al. (1998) Filamentous alpha-synuclein inclusions link multiple sys-
tem atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett
251(3):205–208.
10. Braak H, et al. (2003) Staging of brain pathology related to sporadic Parkinson’s
disease. Neurobiol Aging 24(2):197–211.
11. Li JY, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease
suggest host-to-graft disease propagation. Nat Med 14(5):501–503.
12. Luk KC, et al. (2012) Intracerebral inoculation of pathological α-synuclein initiates a rapidly
progressive neurodegenerative α-synucleinopathy in mice. J Exp Med 209(5):975–986.
E1214 | www.pnas.org/cgi/doi/10.1073/pnas.1524128113 Iljina et al.
13. Luk KC, et al. (2012) Pathological α-synuclein transmission initiates Parkinson-like
neurodegeneration in nontransgenic mice. Science 338(6109):949–953.
14. Masuda-Suzukake M, et al. (2013) Prion-like spreading of pathological α-synuclein in
brain. Brain 136(Pt 4):1128–1138.
15. Osterberg VR, et al. (2015) Progressive aggregation of alpha-synuclein and selective
degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism.
Cell Reports 10(8):1252–1260.
16. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion: The
enigma of Parkinson’s disease pathology spread. Nat Rev Neurosci 9(10):741–745.
17. Golde TE, Borchelt DR, Giasson BI, Lewis J (2013) Thinking laterally about neurode-
generative proteinopathies. J Clin Invest 123(5):1847–1855.
18. Chauhan A, Jeans AF (2015) Is Parkinson’s disease truly a prion-like disorder? An
appraisal of current evidence. Neurol Res Int 2015:345285.
19. Hardy J (2005) Expression of normal sequence pathogenic proteins for neurodegen-
erative disease contributes to disease risk: ‘Permissive templating’ as a general
mechanism underlying neurodegeneration. Biochem Soc Trans 33(Pt 4):578–581.
20. Wood SJ, et al. (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implica-
tions for the pathogenesis of Parkinson’s disease. J Biol Chem 274(28):19509–19512.
21. Fink AL (2006) The aggregation and fibrillation of alpha-synuclein. Acc Chem Res
39(9):628–634.
22. Buell AK, et al. (2014) Solution conditions determine the relative importance of nu-
cleation and growth processes in α-synuclein aggregation. Proc Natl Acad Sci USA
111(21):7671–7676.
23. Zhu M, Li J, Fink AL (2003) The association of alpha-synuclein with membranes affects
bilayer structure, stability, and fibril formation. J Biol Chem 278(41):40186–40197.
24. Auluck PK, Caraveo G, Lindquist S (2010) α-Synuclein: Membrane interactions and
toxicity in Parkinson’s disease. Annu Rev Cell Dev Biol 26:211–233.
25. Galvagnion C, et al. (2015) Lipid vesicles trigger α-synuclein aggregation by stimu-
lating primary nucleation. Nat Chem Biol 11(3):229–234.
26. Shammas SL, et al. (2015) A mechanistic model of tau amyloid aggregation based on
direct observation of oligomers. Nat Commun 6:7025.
27. Cremades N, et al. (2012) Direct observation of the interconversion of normal and
toxic forms of α-synuclein. Cell 149(5):1048–1059.
28. Horrocks MH, et al. (2015) Fast flow microfluidics and single-molecule fluorescence
for the rapid characterization of α-synuclein oligomers. Anal Chem 87(17):8818–8826.
29. Horrocks MH, et al. (2012) Single molecule fluorescence under conditions of fast flow.
Anal Chem 84(1):179–185.
30. Baldwin AJ, et al. (2011) Metastability of native proteins and the phenomenon of
amyloid formation. J Am Chem Soc 133(36):14160–14163.
31. Oosawa F, Asakura S (1975) Thermodynamics of the Polymerization of Protein (Aca-
demic, New York).
32. Cohen SIA, et al. (2011) Nucleated polymerization with secondary pathways. I. Time
evolution of the principal moments. J Chem Phys 135(6):065105.
33. Cohen SIA, Vendruscolo M, Dobson CM, Knowles TPJ (2011) Nucleated polymeriza-
tion with secondary pathways. II. Determination of self-consistent solutions to growth
processes described by non-linear master equations. J Chem Phys 135(6):065106.
34. Garcia GA, Cohen SIA, Dobson CM, Knowles TPJ (2014) Nucleation-conversion-poly-
merization reactions of biological macromolecules with prenucleation clusters. Phys
Rev E Stat Nonlin Soft Matter Phys 89(3):032712.
35. Tosatto L, et al. (2015) Single-molecule FRET studies on alpha-synuclein oligomeri-
zation of Parkinson’s disease genetically related mutants. Sci Rep 5:16696.
36. Lansbury PT, Jr (1997) Structural neurology: Are seeds at the root of neuronal de-
generation? Neuron 19(6):1151–1154.
37. Nonaka T, Watanabe ST, Iwatsubo T, Hasegawa M (2010) Seeded aggregation and
toxicity of alpha-synuclein and tau: Cellular models of neurodegenerative diseases. J Biol
Chem 285(45):34885–34898.
38. Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B (2009) Seeding induced by alpha-
synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.
J Neurochem 111(1):192–203.
39. Lorenzen N, et al. (2014) The role of stable α-synuclein oligomers in the molecular
events underlying amyloid formation. J Am Chem Soc 136(10):3859–3868.
40. Kellie JF, et al. (2014) Quantitative measurement of intact alpha-synuclein proteo-
forms from post-mortem control and Parkinson’s disease brain tissue by intact protein
mass spectrometry. Sci Rep 4:5797.
41. Mollenhauer B, et al. (2011) α-Synuclein and tau concentrations in cerebrospinal fluid of
patients presenting with parkinsonism: A cohort study. Lancet Neurol 10(3):230–240.
42. Ahn TB, et al. (2008) alpha-Synuclein gene duplication is present in sporadic Parkinson
disease. Neurology 70(1):43–49.
43. Singleton AB, et al. (2003) alpha-Synuclein locus triplication causes Parkinson’s dis-
ease. Science 302(5646):841.
44. Princiotta MF, et al. (2003) Quantitating protein synthesis, degradation, and endog-
enous antigen processing. Immunity 18(3):343–354.
45. Chen SW, et al. (2015) Structural characterization of toxic oligomers that are kineti-
cally trapped during α-synuclein fibril formation. Proc Natl Acad Sci USA 112(16):
E1994–E2003.
46. Daturpalli S, Waudby CA, Meehan S, Jackson SE (2013) Hsp90 inhibits α-synuclein
aggregation by interacting with soluble oligomers. J Mol Biol 425(22):4614–4628.
47. Hao R, et al. (2013) Proteasomes activate aggresome disassembly and clearance by
producing unanchored ubiquitin chains. Mol Cell 51(6):819–828.
48. Narayan P, et al. (2014) Rare individual amyloid-β oligomers act on astrocytes to ini-
tiate neuronal damage. Biochemistry 53(15):2442–2453.
49. Bowling AC, Beal MF (1995) Bioenergetic and oxidative stress in neurodegenerative
diseases. Life Sci 56(14):1151–1171.
50. Hashimoto M, et al. (1999) Oxidative stress induces amyloid-like aggregate formation
of NACP/alpha-synuclein in vitro. Neuroreport 10(4):717–721.
51. Hoyer W, et al. (2002) Dependence of alpha-synuclein aggregate morphology on
solution conditions. J Mol Biol 322(2):383–393.
52. Thirunavukkuarasu S, Jares-Erijman EA, Jovin TM (2008) Multiparametric fluorescence
detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-
synuclein. J Mol Biol 378(5):1064–1073.
53. Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA (2000) Fiber diffraction of
synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc
Natl Acad Sci USA 97(9):4897–4902.
54. Orte A, Clarke R, Balasubramanian S, Klenerman D (2006) Determination of the
fraction and stoichiometry of femtomolar levels of biomolecular complexes in an
excess of monomer using single-molecule, two-color coincidence detection. Anal
Chem 78(22):7707–7715.
55. Ying L, Wallace M, Balasubramanian S, Klenerman D (2000) Ratiometric analysis of
single-molecule fluorescence resonance energy transfer using logical combinations of
threshold criteria: A study of 12-mer DNA. J Phys Chem B 104(21):5171–5178.
56. Clarke RW, Orte A, Klenerman D (2007) Optimized threshold selection for single-mol-
ecule two-color fluorescence coincidence spectroscopy. Anal Chem 79(7):2771–2777.
Iljina et al. PNAS | Published online February 16, 2016 | E1215
BI
O
PH
YS
IC
S
A
N
D
CO
M
PU
TA
TI
O
N
A
L
BI
O
LO
G
Y
PN
A
S
PL
U
S
